GEN Poll Majority Favors Moratorium on Synthetic Bio Products
By GEN,
Genetic Engineering & Biotechnology News
| 04. 10. 2012
A majority of respondents to a recent GEN poll would like to see a moratorium on synthetic biotechnology products pending further regulations being put into place. 55.2% of respondents agreed with a group of 111 watchdog organizations including ETC Group and Friends of the Earth, which last month issued a report that called synthetic biology “an extreme form of genetic engineering” and asked for a moratorium on the release and commercial use of synthetic organisms and their products.While 3.9% of respondents were undecided about their position on this matter, 40.9%, did not feel the need for a moratorium.
Synthetic bio is among the latest examples of a scientific achievement that has generated as much fear among portions of the public as did DNA technology and stem cells. Over the years, however, those fears have been addressed by organizations assessing the risks and monitoring potential hazards of new biotechnologies.
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 09.29.2026
Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...
By Maia Hibbett, Wired | 09.09.2026
THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conservatory-trained viola player from Chongqing, China, a lover of science fiction, and an aspiring member of the US Army Reserve Officer Training...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...